ATAI Life Sciences NV
(STU:9VC)
€
1.0905
0.1125 (11.5%)
Market Cap: 181.10 Mil
Enterprise Value: 118.25 Mil
PE Ratio: 0
PB Ratio: 1.18
GF Score: 44/100 Q2 2022 ATAI Life Sciences NV Earnings Presentation Transcript
Aug 15, 2022 / 12:30PM GMT
Release Date Price:
€4.61
(+3.15%)
Gregory L. Weaver
Atai Life Sciences N.V. - CFO
Presentation
Aug 15, 2022 / 12:30PM GMT
=====================
Corporate Participants
=====================
* Florian Brand
Atai Life Sciences N.V. - Co-Founder, MD & CEO
* Gregory L. Weaver
Atai Life Sciences N.V. - CFO
* Srinivas G. Rao
Atai Life Sciences N.V. - Co-Founder & Chief Scientific Officer
* Stephen B. Bardin
Atai Life Sciences N.V. - CFO
=====================
Conference Call Participants
=====================
* Judah C. Frommer
Crédit Suisse AG, Research Division - Senior Analyst
* Lin Tsai
Jefferies LLC, Research Division - Equity Analyst
=====================
-
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot